Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.0bn reported value -5.8% vs Q1 2022
65positions
54.9%in top 10
14 new 32 added 15 reduced 25 sold out vs Q1 2022

Options: 7 call positions ($117.8m notional), 5 put positions ($264.8m notional) – listed below, not included above.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 632,794 $92.2m9.00% 9.00% ReducedShares held: Q3 2021 0, Q4 2021 315.1k, Q1 2022 644.7k, Q2 2022 632.8k -11.9k -11,872 -1.8%
2 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 310,834 $73.2m7.15% 7.15% AddedShares held: Q3 2021 444.5k, Q4 2021 391.9k, Q1 2022 292.2k, Q2 2022 310.8k +18.6k +18,600 6.4%
3 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 889,583 $71.0m6.93% 6.93% AddedShares held: Q3 2021 634.7k, Q4 2021 833.8k, Q1 2022 609.9k, Q2 2022 889.6k +279.6k +279,644 45.9%
4 GLAXOSMITHKLINE PLC SPONSORED ADR SPONSORED ADR 1,594,121 $69.9m6.83% 6.83% AddedShares held: Q3 2021 401.7k, Q4 2021 567.2k, Q1 2022 1.3m, Q2 2022 1.6m +335.0k +334,959 26.6%
5 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 1,020,329 $67.4m6.58% 6.58% AddedShares held: Q3 2021 890.8k, Q4 2021 949.2k, Q1 2022 745.3k, Q2 2022 1.0m +275.1k +275,066 36.9%
6 DANAHER CORPORATION COM DHR DHR 179,659 $45.6m4.45% 4.45% AddedShares held: Q3 2021 147.9k, Q4 2021 170.1k, Q1 2022 159.8k, Q2 2022 179.7k +19.9k +19,891 12.4%
7 SANOFI SPONSORED ADR SNY SNY 879,460 $44.0m4.30% 4.30% NewShares held: Q3 2021 259.1k, Q4 2021 38.7k, Q1 2022 0, Q2 2022 879.5k
8 AVANTOR INC COM AVTR AVTR 1,120,175 $34.8m3.40% 3.40% AddedShares held: Q3 2021 1.3m, Q4 2021 1.1m, Q1 2022 995.2k, Q2 2022 1.1m +124.9k +124,943 12.6%
9 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 4,510,702 $33.9m3.31% 3.31% AddedShares held: Q3 2021 3.6m, Q4 2021 2.3m, Q1 2022 4.1m, Q2 2022 4.5m +367.1k +367,100 8.9%
10 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 8,060,859 $30.2m2.95% 2.95% AddedShares held: Q3 2021 6.0m, Q4 2021 6.4m, Q1 2022 7.1m, Q2 2022 8.1m +934.1k +934,148 13.1%
11 SPDR SER TR S&P BIOTECH XBI XBI 356,067 $26.4m2.58% 2.58% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 356.1k
12 ENVISTA HOLDINGS CORPORATION COM NVST NVST 659,094 $25.4m2.48% 2.48% AddedShares held: Q3 2021 810.9k, Q4 2021 849.3k, Q1 2022 569.4k, Q2 2022 659.1k +89.7k +89,743 15.8%
13 BIOGEN INC COM BIIB BIIB 101,414 $20.7m2.02% 2.02% AddedShares held: Q3 2021 0, Q4 2021 33.0k, Q1 2022 78.0k, Q2 2022 101.4k +23.4k +23,411 30.0%
14 ELEVANCE HEALTH INC COM ELV ELV 42,785 $20.6m2.02% 2.02% AddedShares held: Q3 2021 31.6k, Q4 2021 34.3k, Q1 2022 32.5k, Q2 2022 42.8k +10.3k +10,334 31.8%
15 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 13,284,894 $19.8m1.93% 1.93% AddedShares held: Q3 2021 11.6m, Q4 2021 10.6m, Q1 2022 9.0m, Q2 2022 13.3m +4.3m +4,304,749 47.9%
16 CENTENE CORP DEL COM CNC CNC 233,647 $19.8m1.93% 1.93% AddedShares held: Q3 2021 141.1k, Q4 2021 224.6k, Q1 2022 119.2k, Q2 2022 233.6k +114.5k +114,477 96.1%
17 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 994,362 $19.1m1.87% 1.87% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 994.4k
18 ARGENX SE SPONSORED ADR ARGX ARGX 49,136 $18.6m1.82% 1.82% AddedShares held: Q3 2021 5.7k, Q4 2021 21.5k, Q1 2022 23.1k, Q2 2022 49.1k +26.0k +25,994 112.3%
19 FATE THERAPEUTICS INC COM FATE FATE 726,586 $18.0m1.76% 1.76% AddedShares held: Q3 2021 260.9k, Q4 2021 254.8k, Q1 2022 456.1k, Q2 2022 726.6k +270.5k +270,527 59.3%
20 AMNEAL PHARMACEUTICALS INC COM STK CL A AMRX AMRX 5,494,280 $17.5m1.71% 1.71% AddedShares held: Q3 2021 6.8m, Q4 2021 6.4m, Q1 2022 5.5m, Q2 2022 5.5m +2.8k +2,783 0.1%
21 ABIOMED INC COM ABMD ABMD 69,297 $17.2m1.68% 1.68% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 69.3k
22 NATERA INC COM NTRA NTRA 475,655 $16.9m1.65% 1.65% NewShares held: Q3 2021 112.2k, Q4 2021 102.1k, Q1 2022 0, Q2 2022 475.7k
23 GUARDANT HEALTH INC COM GH GH 406,375 $16.4m1.60% 1.60% AddedShares held: Q3 2021 100.4k, Q4 2021 100.3k, Q1 2022 213.2k, Q2 2022 406.4k +193.2k +193,172 90.6%
24 TANDEM DIABETES CARE INC COM NEW TNDM TNDM 256,268 $15.2m1.48% 1.48% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 256.3k
25 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 552,388 $14.9m1.45% 1.45% ReducedShares held: Q3 2021 0, Q4 2021 592.5k, Q1 2022 636.5k, Q2 2022 552.4k -84.1k -84,065 -13.2%
26 XENON PHARMACEUTICALS INC COM XENE XENE 465,911 $14.2m1.38% 1.38% AddedShares held: Q3 2021 0, Q4 2021 209.5k, Q1 2022 410.0k, Q2 2022 465.9k +55.9k +55,890 13.6%
27 R1 RCM INC COM COM 590,819 $12.4m1.21% 1.21% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 590.8k
28 MARAVAI LIFESCIENCES HLDGS I COM CL A MRVI MRVI 425,364 $12.1m1.18% 1.18% NewShares held: Q3 2021 327.8k, Q4 2021 87.8k, Q1 2022 0, Q2 2022 425.4k
29 LANTHEUS HLDGS INC COM LNTH LNTH 180,053 $11.9m1.16% 1.16% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 180.1k
30 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 78,987 $11.5m1.13% 1.13% AddedShares held: Q3 2021 59.2k, Q4 2021 70.2k, Q1 2022 52.9k, Q2 2022 79.0k +26.1k +26,116 49.4%
31 908 DEVICES INC COM MASS MASS 470,444 $9.7m0.95% 0.95% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 217.1k, Q2 2022 470.4k +253.3k +253,295 116.7%
32 LIQUIDIA CORPORATION COM NEW LQDA LQDA 2,099,708 $9.2m0.89% 0.89% AddedShares held: Q3 2021 929.0k, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 2.1m +722.2k +722,218 52.4%
33 QIAGEN NV SHS NEW SHS NEW 189,907 $9.0m0.88% 0.88% ReducedShares held: Q3 2021 143.1k, Q4 2021 162.5k, Q1 2022 192.7k, Q2 2022 189.9k -2.8k -2,792 -1.4%
34 TARO PHARMACEUTICAL INDS LTD SHS TARO TARO 220,390 $8.0m0.78% 0.78% AddedShares held: Q3 2021 179.4k, Q4 2021 181.2k, Q1 2022 220.3k, Q2 2022 220.4k +104 +104 0.1%
35 HEALTHEQUITY INC COM HQY HQY 127,043 $7.8m0.76% 0.76% ReducedShares held: Q3 2021 114.4k, Q4 2021 333.4k, Q1 2022 144.1k, Q2 2022 127.0k -17.1k -17,097 -11.9%
36 MERUS N V COM MRUS MRUS 287,806 $6.5m0.64% 0.64% AddedShares held: Q3 2021 0, Q4 2021 19.0k, Q1 2022 76.8k, Q2 2022 287.8k +211.0k +210,957 274.5%
37 ILLUMINA INC COM ILMN ILMN 35,266 $6.5m0.63% 0.63% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 38.8k, Q2 2022 35.3k -3.5k -3,493 -9.0%
38 HUMANA INC COM HUM HUM 11,170 $5.2m0.51% 0.51% NewShares held: Q3 2021 24.1k, Q4 2021 27.4k, Q1 2022 0, Q2 2022 11.2k
39 RADIUS HEALTH INC COM NEW RDUS RDUS 502,587 $5.2m0.51% 0.51% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 302.2k, Q2 2022 502.6k +200.4k +200,415 66.3%
40 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 445,592 $5.2m0.50% 0.50% AddedShares held: Q3 2021 160.0k, Q4 2021 194.6k, Q1 2022 155.7k, Q2 2022 445.6k +289.8k +289,849 186.1%
41 AMICUS THERAPEUTICS INC COM FOLD FOLD 478,245 $5.1m0.50% 0.50% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 478.2k
42 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 1,435,077 $4.1m0.40% 0.40% AddedShares held: Q3 2021 397.9k, Q4 2021 1.1m, Q1 2022 1.4m, Q2 2022 1.4m +10.4k +10,427 0.7%
43 GOSSAMER BIO INC COM GOSS GOSS 468,303 $3.9m0.38% 0.38% AddedShares held: Q3 2021 149.9k, Q4 2021 39.9k, Q1 2022 374.7k, Q2 2022 468.3k +93.6k +93,580 25.0%
44 ANAPTYSBIO INC COM ANAB ANAB 182,717 $3.7m0.36% 0.36% AddedShares held: Q3 2021 78.1k, Q4 2021 182.6k, Q1 2022 114.2k, Q2 2022 182.7k +68.6k +68,552 60.0%
45 IONIS PHARMACEUTICALS INC COM IONS IONS 86,311 $3.2m0.31% 0.31% ReducedShares held: Q3 2021 450.5k, Q4 2021 384.8k, Q1 2022 158.8k, Q2 2022 86.3k -72.5k -72,495 -45.6%
46 AFFIMED N V COM COM 1,130,761 $3.1m0.31% 0.31% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.1m
47 AGILENT TECHNOLOGIES INC COM A A 20,264 $2.4m0.24% 0.24% AddedShares held: Q3 2021 18.7k, Q4 2021 19.4k, Q1 2022 19.3k, Q2 2022 20.3k +1.0k +1,009 5.2%
48 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 8,591 $1.7m0.17% 0.17% AddedShares held: Q3 2021 9.4k, Q4 2021 9.8k, Q1 2022 8.2k, Q2 2022 8.6k +428 +428 5.2%
49 PERKINELMER INC COM RVTY RVTY 10,293 $1.5m0.14% 0.14% AddedShares held: Q3 2021 47.1k, Q4 2021 30.9k, Q1 2022 9.8k, Q2 2022 10.3k +505 +505 5.2%
50 IQVIA HLDGS INC COM IQV IQV 6,024 $1.3m0.13% 0.13% ReducedShares held: Q3 2021 6.8k, Q4 2021 24.6k, Q1 2022 59.6k, Q2 2022 6.0k -53.5k -53,546 -89.9%
51 LABORATORY CORP AMER HLDGS COM NEW COM NEW 5,354 $1.3m0.12% 0.12% ReducedShares held: Q3 2021 128.3k, Q4 2021 45.5k, Q1 2022 37.9k, Q2 2022 5.4k -32.6k -32,556 -85.9%
52 AADI BIOSCIENCE INC COM WHWK WHWK 100,817 $1.2m0.12% 0.12% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 150.8k, Q2 2022 100.8k -50.0k -50,000 -33.1%
53 ICON PLC SHS ICLR ICLR 5,587 $1.2m0.12% 0.12% ReducedShares held: Q3 2021 71.9k, Q4 2021 51.9k, Q1 2022 46.8k, Q2 2022 5.6k -41.2k -41,229 -88.1%
54 DEXCOM INC COM DXCM DXCM 14,468 $1.1m0.11% 0.11% ReducedShares held: Q3 2021 25.6k, Q4 2021 25.6k, Q1 2022 113.6k, Q2 2022 14.5k -99.1k -99,148 -87.3%
55 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 38,342 $1.1m0.11% 0.11% ReducedShares held: Q3 2021 0, Q4 2021 63.2k, Q1 2022 100.2k, Q2 2022 38.3k -61.8k -61,845 -61.7%
56 REPLIGEN CORP COM RGEN RGEN 5,693 $924.5k0.09% 0.09% ReducedShares held: Q3 2021 4.4k, Q4 2021 4.6k, Q1 2022 36.5k, Q2 2022 5.7k -30.8k -30,828 -84.4%
57 MILESTONE PHARMACEUTICALS IN COM MIST MIST 147,165 $905.1k0.09% 0.09% UnchangedShares held: Q3 2021 113.6k, Q4 2021 147.2k, Q1 2022 147.2k, Q2 2022 147.2k
58 MASIMO CORP COM MASI MASI 5,984 $781.9k0.08% 0.08% ReducedShares held: Q3 2021 67.0k, Q4 2021 0, Q1 2022 209.0k, Q2 2022 6.0k -203.0k -202,986 -97.1%
59 HESKA CORP COM RESTRC NEW HSKA HSKA 7,772 $734.5k0.07% 0.07% AddedShares held: Q3 2021 4.5k, Q4 2021 4.5k, Q1 2022 5.8k, Q2 2022 7.8k +1.9k +1,936 33.2%
60 SHOCKWAVE MED INC COM SWAV SWAV 3,300 $630.9k0.06% 0.06% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 3.3k
61 AC IMMUNE SA SHS ACIU ACIU 124,589 $449.8k0.04% 0.04% UnchangedShares held: Q3 2021 221.7k, Q4 2021 153.4k, Q1 2022 124.6k, Q2 2022 124.6k
62 SONIDA SENIOR LIVING INC COM SNDA SNDA 15,209 $319.4k0.03% 0.03% UnchangedShares held: Q3 2021 0, Q4 2021 15.2k, Q1 2022 15.2k, Q2 2022 15.2k
63 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 59,065 $144.1k0.01% 0.01% ReducedShares held: Q3 2021 114.0k, Q4 2021 114.0k, Q1 2022 114.0k, Q2 2022 59.1k -54.9k -54,943 -48.2%
64 BOLT BIOTHERAPEUTICS INC COM COM 31,172 $63.6k0.01% 0.01% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 31.2k
65 GLYCOMIMETICS INC COM COM 100,579 $60.1k0.01% 0.01% UnchangedShares held: Q3 2021 0, Q4 2021 100.0k, Q1 2022 100.6k, Q2 2022 100.6k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
ASCENDIS PHARMA A/S 417,172 $49.0m417.2k shares
R1 RCM INC RCM RCM 1,361,506 $36.4m1.4m shares
HCA HEALTHCARE INC HCA HCA 111,440 $27.9m111.4k shares
ARK ETF TR ARKG ARKG 470,506 $21.6m470.5k shares
MCKESSON CORP MCK MCK 52,375 $16.1m52.4k shares
NANOSTRING TECHNOLOGIES INC NSTG NSTG 280,695 $9.8m280.7k shares
ORTHO CLINICAL DIAGNOSTICS H OCDX OCDX 445,059 $8.3m445.1k shares
SYNEOS HEALTH INC INCR INCR 81,416 $6.6m81.4k shares
EXELIXIS INC EXEL EXEL 203,156 $4.6m203.2k shares
IRHYTHM TECHNOLOGIES INC IRTC IRTC 27,047 $4.3m27.0k shares
KARUNA THERAPEUTICS INC 15,934 $2.0m15.9k shares
MERCK & CO INC MRK MRK 9,483 $2.0m9.5k shares
AUTOLUS THERAPEUTICS PLC AUTL AUTL 371,540 $1.5m371.5k shares
ENSIGN GROUP INC ENSG ENSG 10,397 $936.4k10.4k shares
KODIAK SCIENCES INC KOD KOD 91,200 $704.1k91.2k shares
ASSEMBLY BIOSCIENCES INC 280,000 $576.8k280.0k shares
SPERO THERAPEUTICS INC SPRO SPRO 59,639 $518.9k59.6k shares
ADAPTIMMUNE THERAPEUTICS PLC ADAPY ADAPY 237,086 $488.4k237.1k shares
SURGALIGN HOLDINGS INC RTIX RTIX 1,573,802 $478.9k1.6m shares
BIO-TECHNE CORP TECH TECH 1,062 $459.9k1.1k shares
MEREO BIOPHARMA GROUP PLC MREO MREO 370,170 $414.6k370.2k shares
CYCLERION THERAPEUTICS INC 371,955 $412.9k372.0k shares
AVROBIO INC 295,369 $389.9k295.4k shares
ORCHARD THERAPEUTICS PLC ORTX ORTX 419,581 $298.7k419.6k shares
CLOVIS ONCOLOGY INC CLVS CLVS 30,000 $60.6k30.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR S&P 500 ETF TR SPY · Put SPYPut 465,000 $175.4m465.0k shares New
INVESCO QQQ TR QQQ · Put QQQPut 270,000 $75.7m270.0k shares Added
GLAXOSMITHKLINE PLC Call Call 1,553,700 $67.6m1.6m shares Unchanged
ASTRAZENECA PLC Call Call 300,300 $19.8m300.3k shares Reduced
SPDR SER TR XBI · Call XBICall 259,800 $19.3m259.8k shares New
ISHARES TR IWM · Put IWMPut 50,000 $8.5m50.0k shares New
CELLDEX THERAPEUTICS INC NEW CLDX · Call CLDXCall 191,600 $5.2m191.6k shares New
MERCK & CO INC MRK · Call MRKCall 48,700 $4.4m48.7k shares Unchanged
ARK ETF TR ARKK · Put ARKKPut 90,000 $3.6m90.0k shares New
CELLDEX THERAPEUTICS INC NEW CLDX · Put CLDXPut 60,600 $1.6m60.6k shares New
COMMUNITY HEALTH SYS INC NEW CYH · Call CYHCall 200,000 $750.0k200.0k shares New
TEVA PHARMACEUTICAL INDS LTD Call Call 92,900 $698.6k92.9k shares Unchanged

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17